The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy
Authors
Keywords
Diabetes mellitus, Mouse models, Kidneys, Fibrosis, Collagens, Extracellular matrix, Inflammation, Renal system
Journal
PLoS One
Volume 13, Issue 2, Pages e0192800
Publisher
Public Library of Science (PLoS)
Online
2018-02-10
DOI
10.1371/journal.pone.0192800
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammation and metabolism in tissue repair and regeneration
- (2017) Sabine A. Eming et al. SCIENCE
- Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions
- (2017) Eugene Y. Chiang et al. Nature Communications
- Role of KCa3.1 Channels in Macrophage Polarization and Its Relevance in Atherosclerotic Plaque InstabilityHighlights
- (2016) Rende Xu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- OX40L blockade protects against inflammation-driven fibrosis
- (2016) Muriel Elhai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis
- (2016) Xiao-Ming Meng et al. Cell Death & Disease
- A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications
- (2016) Francesca Conserva et al. Journal of Diabetes Research
- KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways
- (2016) Chunling Huang et al. Scientific Reports
- Inflammatory Cytokines in Diabetic Nephropathy
- (2015) Javier Donate-Correa et al. Journal of Diabetes Research
- Blood Pressure, Hypertension, RAAS Blockade, and Drug Therapy in Diabetic Kidney Disease
- (2014) Hala Yamout et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- High Glucose Induces CCL20 in Proximal Tubular Cells via Activation of the KCa3.1 Channel
- (2014) Chunling Huang et al. PLoS One
- Blockade of KCa3.1 Ameliorates Renal Fibrosis Through the TGF-β1/Smad Pathway in Diabetic Mice
- (2013) Chunling Huang et al. DIABETES
- Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways
- (2013) Chunling Huang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis
- (2013) C. Huang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Inflammation and the pathogenesis of diabetic nephropathy
- (2012) Jun Wada et al. CLINICAL SCIENCE
- TGF-β: the sword, the wand, and the shield of FOXP3+ regulatory T cells
- (2011) Dat Q. Tran Journal of Molecular Cell Biology
- Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease
- (2010) Ralf Köhler et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Mechanisms of Tubulointerstitial Fibrosis
- (2010) M. Zeisberg et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pathologic Classification of Diabetic Nephropathy
- (2010) T. W. C. Tervaert et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renal fibrosis: novel insights into mechanisms and therapeutic targets
- (2010) Peter Boor et al. Nature Reviews Nephrology
- Therapeutic potential of KCa3.1 blockers: recent advances and promising trends
- (2010) Heike Wulff et al. Expert Review of Clinical Pharmacology
- TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Therapeutic Intervention in Diabetic Nephropathy
- (2009) Claire E. Hills et al. AMERICAN JOURNAL OF NEPHROLOGY
- The K+channels KCa3.1 and Kv1.3 as novel targets for asthma therapy
- (2009) Peter Bradding et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mouse Models of Diabetic Nephropathy
- (2009) F. C. Brosius et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels
- (2009) I. Grgic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
- (2008) K. I. Ataga et al. BLOOD
- KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?
- (2008) Chuan-Chu Chou et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Transforming growth factor-β/connective tissue growth factor axis in the kidney
- (2007) Weier Qi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started